Part X. Potential Role of Endogenous Opioids in Schizophrenia and Affective Disorders: DEPRESSIVE PHENOMENOLOGY AND LEVELS OF CEREBROSPINAL FLUID ENDORPHINS *

No abstract is available for this paper.

• Publication year

  1982

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  1982-12-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/j.1749-6632.1982.tb39510.xPMID 6961865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Letter: A rapid assay of affinity for the narcotic receptor in rat brain: application to methadone analogues.

  2009cited by this paper
• Correlation of anxiety and related symptoms with cerebrospinal fluid 5-hydroxyindoleacetic acid in depressed women

  2005cited by this paper
• Depressive symptom patterns and urinary MHPG excretion.

  1982cited by this paper
• Patterns of depression reflected in pituitary - thyroid and pituitary - adrenal endocrine changes.

  1982cited by this paper
• Two adrenal opioid polypeptides: proposed intermediates in the processing of proenkephalin.

  1981cited by this paper
• Aversive effects of naltrexone in subjects not dependent on opiates.

  1981cited by this paper
• Biological markers in major depressive disorders : a clinical and multivariate study

  1981cited by this paper
• A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility.

  1981cited by this paper
• Alcohol and cardiovascular disorders.

  1981cited by this paper
• Chemical characteristics of endorphins in human cerebrospinal fluid

  1980cited by this paper
• Analgesia to painful stimuli in affective illness.

  1979cited by this paper
• Use of the Research Diagnostic Criteria and the Schedule for Affective Disorders and Schizophrenia to study affective disorders.

  1979cited by this paper
• Dynorphin-(1-13), an extraordinarily potent opioid peptide.

  1979cited by this paper
• Endorphins in psychiatry: an overview and a hypothesis.

  1978cited by this paper
• Endorphins in human cerebrospinal fluid: Clinical correlations to some psychotic states

  1978cited by this paper
• A diagnostic interview: the schedule for affective disorders and schizophrenia.

  1978cited by this paper
• Naloxone (Narcan®) treatment in depression: Clinical observations and effects on CSF endorphins and monoamine metabolites

  1977cited by this paper
• 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?

  1976cited by this paper
• Morphine-like ligand for opiate receptors in human CSF.

  1975cited by this paper
• EXPERIMENTALLY INDUCED PAIN IN PATIENTS WITH DEPRESSIVE DISORDERS

  1974cited by this paper
• The Diagnostic Interview

  1971cited by this paper
• Clinical antidepressant activity of cyclazocine—a narcotic antagonist

  1970cited by this paper

• Association Between Placebo-Activated Neural Systems and Antidepressant Responses: Neurochemistry of Placebo Effects in Major Depression.

  2015cites this paper
• Gut Uptake, Brain and Behaviour

  2014cites this paper
• The Influence of Discouragement, Anxiety and Anger on Pain: An Examination of the Role of Endogenous Opioids

  2008cites this paper
• Endorphin levels in human cerebrospinal fluid during alcohol intoxication and withdrawal

  2004cites this paper
• CSF Opioids in Pathophysiology

  1993cites this paper
• Effect of mixed (RB 38A) and selective (RB 38B) inhibitors of enkephalin degrading enzymes on a model of depression in the rat.

  1993cites this paper
• CSF opioids in panic disorder.

  1991cites this paper
• Neuropeptide Modulation of Development and Behavior

  1990cites this paper
• A cerebrospinal fluid study of the pathophysiology of panic disorder associated with alcoholism

  1990cites this paper
• Opioid Peptides and Mood: Neuroendocrine Aspects

  1988cites this paper
• Opioid peptides in the cerebrospinal fluid of psychiatric patients.

  1986cites this paper
• Hallucinations in patients with major depression. Interactions between CSF monoaminergic and endorphinergic indices.

  1985cites this paper
• Delta-sleep inducing peptide in cerebrospinal fluid from schizophrenics, depressives and healthy volunteers.

  1985cites this paper
• Endorphins and Mental Disease

  1985cites this paper
• Endorphin activity in childhood psychosis. Spinal fluid levels in 24 cases.

  1985cites this paper
• Prolactin response to morphine in depression.

  1984cites this paper
• CSF and plasma beta-casomorphin-like opioid peptides in postpartum psychosis.

  1984cites this paper
• Endorfiner och ångest

  1984cites this paper
• Endorphins and psychiatry: pre-clinical perspectives.

  1984cites this paper
• Low levels of somatostatin in human CSF mark depressive episodes.

  1984cites this paper
• Endorphins in psychiatry.

  1984cites this paper
• Approaches to neuropeptide and, in particular, endorphin measurements.

  1984cites this paper
• Depression and CSF endorphin fraction I: seasonal variation and higher levels in unipolar than bipolar patients.

  1983cites this paper
• MULTIPLE FORMS OF NEUROPEPTIDES IN HUMAN CSF AND THEIR SIGNIFICANCE

  1983cites this paper